Bausch & Lomb offshoot ISTA
Pharmaceuticals has agreed to
pay US$33.5m in settlement of
US Department of Justice claims
arising from its marketing of
Xibrom (bromfenac).The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 27 May 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 13
QUEENSLAND One Nation Senator, Malcolm Roberts, stirred the medicinal cannabis debate in parliament this week claiming the Federal Minister for Health, Greg Hunt, is playing a “pharmaceutical game” with the medicine.